Xue F, Guo S, Liu P, Chen W, Chen Y, Wen Q, Hua H, Cao Y, Feng X, Sun J, Xu C, Yang R. First-in-human pharmacokinetic, safety, and preliminary efficacy studies of single- and multiple-dose FRSW117, a novel PEGylated recombinant factor VIII-Fc fusion protein with an extended half-life, in patients with severe hemophilia A. haematol [Internet]. 2025Nov.1 [cited 2025Dec.5];110(11):2786-91. Available from: https://haematologica.org/article/view/12101